|
|
|
|
||
ICR: Jan 14, 2021 completing RA Dx P2b arm 3, 16 patient data package, to be used in next several days to move forward with FDA. Will FDA 60 calander day review period end up to be 3, 4, 5, 6, 7, 8, or 9 weeks for response/meeting?...eom |
return to message board, top of board |